These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 29485856)
1. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery. Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856 [TBL] [Abstract][Full Text] [Related]
2. Novel high-coverage targeted metabolomics method (SWATHtoMRM) for exploring follicular fluid metabolome alterations in women with recurrent spontaneous abortion undergoing in vitro fertilization. Song J; Wang X; Guo Y; Yang Y; Xu K; Wang T; Sa Y; Yuan L; Jiang H; Guo J; Sun Z Sci Rep; 2019 Jul; 9(1):10873. PubMed ID: 31350457 [TBL] [Abstract][Full Text] [Related]
3. Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics. Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524 [TBL] [Abstract][Full Text] [Related]
4. Development and application of time staggered/mass staggered-globally optimized targeted mass spectrometry. Zhong F; Xu M; Zhu J J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():80-88. PubMed ID: 31071582 [TBL] [Abstract][Full Text] [Related]
6. Large-scale targeted metabolomics method for metabolite profiling of human samples. Cao G; Song Z; Hong Y; Yang Z; Song Y; Chen Z; Chen Z; Cai Z Anal Chim Acta; 2020 Aug; 1125():144-151. PubMed ID: 32674760 [TBL] [Abstract][Full Text] [Related]
7. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery. Peng J; Chen YT; Chen CL; Li L Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652 [TBL] [Abstract][Full Text] [Related]
8. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. Ni Y; Xie G; Jia W J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552 [TBL] [Abstract][Full Text] [Related]
9. Database-Assisted Globally Optimized Targeted Mass Spectrometry (dGOT-MS): Broad and Reliable Metabolomics Analysis with Enhanced Identification. Shi X; Wang S; Jasbi P; Turner C; Hrovat J; Wei Y; Liu J; Gu H Anal Chem; 2019 Nov; 91(21):13737-13745. PubMed ID: 31556994 [TBL] [Abstract][Full Text] [Related]
11. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336 [TBL] [Abstract][Full Text] [Related]
12. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring. Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Abu Zaid M; Chiorean EG; Raftery D Anal Bioanal Chem; 2015 Oct; 407(26):7857-63. PubMed ID: 26342311 [TBL] [Abstract][Full Text] [Related]
13. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers. You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963 [TBL] [Abstract][Full Text] [Related]
14. A Simultaneous Metabolic Profiling and Quantitative Multimetabolite Metabolomic Method for Human Plasma Using Gas-Chromatography Tandem Mass Spectrometry. Savolainen OI; Sandberg AS; Ross AB J Proteome Res; 2016 Jan; 15(1):259-65. PubMed ID: 26615962 [TBL] [Abstract][Full Text] [Related]
15. Analytical considerations for (un)-targeted metabolomic studies with special focus on forensic applications. Boxler MI; Schneider TD; Kraemer T; Steuer AE Drug Test Anal; 2019 May; 11(5):678-696. PubMed ID: 30408838 [TBL] [Abstract][Full Text] [Related]
16. Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry. Zhou J; Yin Y Analyst; 2016 Nov; 141(23):6362-6373. PubMed ID: 27722450 [TBL] [Abstract][Full Text] [Related]
17. Multiple reaction monitoring-ion pair finder: a systematic approach to transform nontargeted mode to pseudotargeted mode for metabolomics study based on liquid chromatography-mass spectrometry. Luo P; Dai W; Yin P; Zeng Z; Kong H; Zhou L; Wang X; Chen S; Lu X; Xu G Anal Chem; 2015; 87(10):5050-5. PubMed ID: 25884293 [TBL] [Abstract][Full Text] [Related]
18. Ion-Pair Selection Method for Pseudotargeted Metabolomics Based on SWATH MS Acquisition and Its Application in Differential Metabolite Discovery of Type 2 Diabetes. Wang L; Su B; Zeng Z; Li C; Zhao X; Lv W; Xuan Q; Ouyang Y; Zhou L; Yin P; Peng X; Lu X; Lin X; Xu G Anal Chem; 2018 Oct; 90(19):11401-11408. PubMed ID: 30148611 [TBL] [Abstract][Full Text] [Related]
19. Methods used to increase the comprehensive coverage of urinary and plasma metabolomes by MS. Chen Y; Xu J; Zhang R; Abliz Z Bioanalysis; 2016 May; 8(9):981-97. PubMed ID: 27079429 [TBL] [Abstract][Full Text] [Related]